Akihito Tsuji Selected Research

Akihito Tsuji Research Topics

Disease

60	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 07/2002
35	Neoplasms (Cancer) 01/2024 - 12/2003
33	Stomach Neoplasms (Stomach Cancer) 10/2023 - 12/2003
11	Neutropenia 12/2021 - 10/2012
6	Adenocarcinoma 10/2022 - 10/2012
6	Febrile Neutropenia 12/2021 - 10/2014
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2016
5	Disease Progression 11/2021 - 08/2012
5	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2002
5	Diarrhea 07/2020 - 02/2015
4	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 06/2014
4	Hepatocellular Carcinoma (Hepatoma) 04/2020 - 03/2003
3	Esophageal Neoplasms (Esophageal Cancer) 04/2024 - 02/2002
3	Colonic Neoplasms (Colon Cancer) 09/2022 - 06/2011
3	Fatigue 01/2022 - 01/2018
3	Carcinoma (Carcinomatosis) 11/2020 - 01/2005
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 12/2020
2	Esophageal Squamous Cell Carcinoma 10/2022 - 01/2021
2	Nausea 01/2022 - 01/2017
2	Anorexia 01/2018 - 01/2016
2	Anemia 01/2018 - 07/2016
2	Hypertension (High Blood Pressure) 04/2017 - 06/2015
2	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2017 - 01/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2022
1	Fistula 02/2022
1	Hemorrhage 02/2022
1	Residual Neoplasm 11/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2020
1	Breast Neoplasms (Breast Cancer) 03/2019
1	Infections 02/2019

Drug/Important Bio-Agent (IBA)

32	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2022 - 09/2010
26	Irinotecan (Camptosar)FDA LinkGeneric 06/2023 - 09/2010
19	Cetuximab (Erbitux)FDA Link 06/2023 - 01/2012
19	Bevacizumab (Avastin)FDA Link 09/2022 - 06/2011
19	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 02/2002
16	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2002
9	trifluridine tipiracil drug combinationIBA 11/2021 - 10/2012
8	Leucovorin (Folinic Acid)FDA Link 01/2022 - 09/2010
8	regorafenibIBA 11/2021 - 06/2015
7	ErbB Receptors (EGF Receptor)IBA 05/2022 - 01/2016
7	Capecitabine (Xeloda)FDA Link 12/2021 - 01/2016
7	Gemcitabine FDA Link 01/2021 - 06/2014
7	PlatinumIBA 01/2021 - 02/2014
7	S-1 plus cisplatinIBA 09/2019 - 02/2014
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
6	Panitumumab (Vectibix)FDA Link 09/2022 - 08/2016
5	RamucirumabIBA 01/2023 - 04/2017
5	Circulating Tumor DNAIBA 01/2022 - 11/2020
4	pembrolizumabIBA 04/2024 - 01/2021
4	130-nm albumin-bound paclitaxelIBA 01/2023 - 07/2014
4	Monoclonal AntibodiesIBA 01/2022 - 06/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 06/2011
3	NivolumabIBA 10/2023 - 01/2019
3	TegafurIBA 01/2022 - 09/2010
3	XELOXIBA 09/2017 - 01/2016
2	Angiogenesis InhibitorsIBA 01/2024 - 05/2022
2	Albumin-Bound Paclitaxel FDA Link 01/2023 - 07/2014
2	UracilIBA 01/2022 - 02/2015
2	folfirinoxIBA 01/2022 - 01/2021
2	afliberceptIBA 11/2020 - 08/2018
2	AntibodiesIBA 11/2020 - 01/2012
2	human ERBB2 proteinIBA 10/2020 - 07/2014
2	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 02/2019
2	CreatinineIBA 01/2018 - 07/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2014 - 01/2011
1	binimetinibIBA 06/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2023
1	encorafenibIBA 06/2023
1	B7-H1 AntigenIBA 10/2022
1	Epidermal Growth Factor (EGF)IBA 09/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	resminostatIBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	fms-Like Tyrosine Kinase 3IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 11/2020
1	tributyl phosphate (TBP)IBA 10/2020
1	Cell-Free Nucleic AcidsIBA 10/2020
1	Trastuzumab (Herceptin)FDA Link 10/2020
1	Tyrosine Kinase InhibitorsIBA 04/2020
1	2-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA 03/2019
1	Immunoglobulin G (IgG)IBA 02/2019
1	AntigensIBA 02/2019
1	avelumabIBA 02/2019
1	MicellesIBA 12/2018
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	thymidine kinase 1IBA 12/2018
1	taxaneIBA 11/2018
1	InterferonsIBA 08/2018

Therapy/Procedure

56	Drug Therapy (Chemotherapy) 04/2024 - 07/2002
41	Therapeutics 01/2024 - 02/2002
11	Adjuvant Chemotherapy 01/2021 - 02/2002
9	Combination Drug Therapy (Combination Chemotherapy) 01/2022 - 03/2003
4	Neoadjuvant Therapy 01/2022 - 01/2005
4	Hepatectomy 01/2021 - 06/2014
2	Glycemic Control 01/2024 - 01/2024
2	Gastrectomy 11/2020 - 01/2017
1	Endoscopes 05/2023
1	Surgical Instruments (Clip) 02/2022
1	Drug Tapering 12/2020
1	Operative Surgical Procedures 05/2019